These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16842160)

  • 21. Human plasma kallikrein-kinin system: physiological and biochemical parameters.
    Bryant JW; Shariat-Madar Z
    Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):234-50. PubMed ID: 19689262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.
    Espinola RG; Uknis A; Sainz IM; Isordia-Salas I; Pixley R; DeLa Cadena R; Long W; Agelan A; Gaughan J; Adam A; Colman RW
    Am J Pathol; 2004 Sep; 165(3):969-76. PubMed ID: 15331420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cleaved high-molecular-weight kininogen inhibits neointima formation following vascular injury.
    Daniel JM; Reich F; Dutzmann J; Weisheit S; Teske R; Gündüz D; Bauersachs J; Preissner KT; Sedding DG
    Thromb Haemost; 2015 Aug; 114(3):603-13. PubMed ID: 26063414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kininostatin associates with membrane rafts and inhibits alpha(v)beta3 integrin activation in human umbilical vein endothelial cells.
    Wu Y; Rizzo V; Liu Y; Sainz IM; Schmuckler NG; Colman RW
    Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1968-75. PubMed ID: 17585065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-chain high molecular weight kininogen induces endothelial cell apoptosis and inhibits angiogenesis: partial activity within domain 5.
    Zhang JC; Claffey K; Sakthivel R; Darzynkiewicz Z; Shaw DE; Leal J; Wang YC; Lu FM; McCrae KR
    FASEB J; 2000 Dec; 14(15):2589-600. PubMed ID: 11099478
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of high-molecular-weight kininogen with endothelial cell binding proteins suPAR, gC1qR and cytokeratin 1 determined by surface plasmon resonance (BiaCore).
    Pixley RA; Espinola RG; Ghebrehiwet B; Joseph K; Kao A; Bdeir K; Cines DB; Colman RW
    Thromb Haemost; 2011 Jun; 105(6):1053-9. PubMed ID: 21544310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Host stromal bradykinin B2 receptor signaling facilitates tumor-associated angiogenesis and tumor growth.
    Ikeda Y; Hayashi I; Kamoshita E; Yamazaki A; Endo H; Ishihara K; Yamashina S; Tsutsumi Y; Matsubara H; Majima M
    Cancer Res; 2004 Aug; 64(15):5178-85. PubMed ID: 15289322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of angiogenesis by two-chain high molecular weight kininogen (HKa) and kininogen-derived polypeptides.
    Zhang JC; Qi X; Juarez J; Plunkett M; Donaté F; Sakthivel R; Mazar AP; McCrae KR
    Can J Physiol Pharmacol; 2002 Feb; 80(2):85-90. PubMed ID: 11934260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ferritin blocks inhibitory effects of two-chain high molecular weight kininogen (HKa) on adhesion and survival signaling in endothelial cells.
    Tesfay L; Huhn AJ; Hatcher H; Torti FM; Torti SV
    PLoS One; 2012; 7(7):e40030. PubMed ID: 22768328
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor.
    Colman RW; Pixley RA; Najamunnisa S; Yan W; Wang J; Mazar A; McCrae KR
    J Clin Invest; 1997 Sep; 100(6):1481-7. PubMed ID: 9294114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G Protein-Coupled Kinin Receptors and Immunity Against Pathogens.
    Scharfstein J; Ramos PIP; Barral-Netto M
    Adv Immunol; 2017; 136():29-84. PubMed ID: 28950949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of tumor angiogenesis in vivo by a monoclonal antibody targeted to domain 5 of high molecular weight kininogen.
    Song JS; Sainz IM; Cosenza SC; Isordia-Salas I; Bior A; Bradford HN; Guo YL; Pixley RA; Reddy EP; Colman RW
    Blood; 2004 Oct; 104(7):2065-72. PubMed ID: 15161672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A monoclonal antibody against kininogen reduces inflammation in the HLA-B27 transgenic rat.
    Keith JC; Sainz IM; Isordia-Salas I; Pixley RA; Leathurby Y; Albert LM; Colman RW
    Arthritis Res Ther; 2005; 7(4):R769-76. PubMed ID: 15987478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the plasma kallikrein-kinin system on human lung epithelial cells.
    Vergiliana JF; Asokananthan N; Stewart GA
    Biol Chem; 2010 Sep; 391(9):1067-77. PubMed ID: 20536386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of cell adhesion by high molecular weight kininogen.
    Asakura S; Hurley RW; Skorstengaard K; Ohkubo I; Mosher DF
    J Cell Biol; 1992 Jan; 116(2):465-76. PubMed ID: 1370494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B2-kinin receptor plays a key role in B1-, angiotensin converting enzyme inhibitor-, and vascular endothelial growth factor-stimulated in vitro angiogenesis in the hypoxic mouse heart.
    Sanchez de Miguel L; Neysari S; Jakob S; Petrimpol M; Butz N; Banfi A; Zaugg CE; Humar R; Battegay EJ
    Cardiovasc Res; 2008 Oct; 80(1):106-13. PubMed ID: 18566101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High molecular weight kininogen binds to laminin--characterization and kinetic analysis.
    Schousboe I; Nystrøm B
    FEBS J; 2009 Sep; 276(18):5228-38. PubMed ID: 19691495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.
    Kaplan AP; Joseph K
    Adv Immunol; 2014; 121():41-89. PubMed ID: 24388213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biochemical characterization of a novel high-affinity and specific plasma kallikrein inhibitor.
    Kolte D; Bryant J; Holsworth D; Wang J; Akbari P; Gibson G; Shariat-Madar Z
    Br J Pharmacol; 2011 Apr; 162(7):1639-49. PubMed ID: 21175583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antiangiogenic activity of cleaved high molecular weight kininogen is mediated through binding to endothelial cell tropomyosin.
    Zhang JC; Donate F; Qi X; Ziats NP; Juarez JC; Mazar AP; Pang YP; McCrae KR
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12224-9. PubMed ID: 12196635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.